Loading...

Haemonetics Corporation

HAE•NYSE
Healthcare
Medical - Instruments & Supplies
$56.85
$-0.43(-0.75%)
U.S. Market opens in 13h 47m

Haemonetics Corporation (HAE) Stock Overview

Explore Haemonetics Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.6B
P/E Ratio27.20
EPS (TTM)$3.63
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$59.06
3 Months$71.18
1 Year Target$56.88

HAE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haemonetics Corporation (HAE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $56.88.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 27.20 and a market capitalization of 2.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.70%
5-Day Change
-0.35%
1-Month Change
-7.69%
3-Month Change
-6.25%
6-Month Change
-24.35%
Year-to-Date (YTD) Change
-29.03%
1-Year Change
-17.99%
3-Year Change
-32.38%
5-Year Change
0.65%
All-Time (Max) Change
857.98%

Contact Information

https://www.haemonetics.com
781 848 7100
125 Summer Street, Boston, MA, 02110

Company Facts

3,657 Employees
IPO DateMay 10, 1991
CountryUS
Actively Trading

Frequently Asked Questions